Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from ...

With decades of experience in pharmaceutical development and extensive genetic medicine expertise, Doug E. Williams, Ph.D., and Murray Stewart, ...

This guide covers all the logo design rules, best practices, tips, examples, and more to equip you with the knowledge for crafting brilliant logos. Logos are one of the most vital elements of any ...

From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...

Biogen and Ionis Pharmaceuticals’ Spinraza could be on the US market within weeks after a phase 3 trial in the rare neuromuscular disorder, spinal muscular atrophy, met its goal. The ...

Spinal muscular atrophy (SMA) therapy Spinraza has been a key earner for Biogen in recent years, but with sales now heading into reverse, the company is looking to extend its franchise.

Shane here! I just wanted to quick put up some reflections on my day today. I got my 7th Spinraza injection and it was quite a long day! Manfred considering petition to have Rose posthumously ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

© 2025 NBCUniversal Media, LLCApple®, Apple logo® and App Store® are registered trademarks of Apple Inc.

With a powerful logo and striking color, the brand captures and amplifies the spirit and energy of the WTA, bringing the drama of women's tennis to life like never before. Honoring the WTA's ...

Spinraza (nusinersen) treatment may help restore balance to the levels of some lipids, fat-like molecules that are lower in the cerebrospinal fluid (CSF) of children with spinal muscular atrophy (SMA) ...